A strategy for the reactivation of the pro-apoptotic p53 activities in such tumours is therefore to interrupt the p53–HDM2 feed-back loop, either by blocking the protein–protein interaction between the p53 N-terminal domain and HDM2, or by inhibiting the E3 ligase activity of HDM2.4 The gene discussed is TP53; the disease is neoplasm.